JOsh Fegan Archives | Cannabiz

Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors

by Steve Jones March 21, 2025March 26, 2025

Australia’s medical cannabis market has adopted a California-style approach to the drug, Althea chief executive Josh […]

Impairment charge sees Althea losses sink to $32m despite revenue growth

by Steve Jones August 30, 2024September 2, 2024

Althea suffers rocky end of year but posts bullish FY25 guidance

by Steve Jones July 31, 2024July 31, 2024

Althea shares tumble after announcing $2m capital raise for product expansion

by Steve Jones July 16, 2024July 17, 2024

Senior team confirmed as Althea eyes emerging European markets

by Steve Jones June 26, 2024June 26, 2024

josh fegan

Althea to cut further costs amid cash flow concerns and ongoing losses

by Steve Jones March 1, 2024March 4, 2024